AnalystsMichael OkunewitchMichael Okunewitch's Stock Forecasts
AnalystsMichael Okunewitch
Analyst Ranking
Bottom 5%
#4743 out of 4986 analysts
Average Return
-11.66%
Win Rate
27%7 out of 26
Risk vs Reward
Poor
Good
Michael Okunewitch's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lexaria Bioscience CorpLEXX | +215.61% | $0.87 | $2.73 | 2023-07-20 - 2024-07-19 | Strong Buy |
Anebulo Pharmaceuticals IncANEB | +145.54% | $1.01 | $2.48 | 2025-05-14 - 2025-08-19 | Strong Buy |
Lineage Cell Therapeutics IncLCTX | +113.79% | $0.58 | $1.24 | 2025-01-09 - 2025-08-19 | Strong Buy |
Citius Oncology IncCTOR | +80.85% | $0.94 | $1.70 | 2024-11-26 - 2025-08-19 | Strong Buy |
Chemomab Therapeutics LtdCMMB | +52.33% | $0.81 | $1.24 | 2024-05-12 - 2025-05-12 | Strong Buy |
Michael Okunewitch Analyst Color
Get additional color on Michael Okunewitch's coverage of popular stocks
Michael Okunewitch's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Hcw Biologics IncHCWB | 2 | Strong Buy | $35.00 | +883.15% | Maintains | 3 months ago |
Anebulo Pharmaceuticals IncANEB | 2 | Strong Buy | $3.00 | +20.97% | Maintains | 3 months ago |
Radiopharm Theranostics LtdRADX | 1 | Strong Buy | $12.00 | +139.04% | Initiates Coverage On | 4 months ago |
Chemomab Therapeutics LtdCMMB | 2 | Strong Buy | $7.00 | +652.69% | Maintains | 6 months ago |
Mainz Biomed NvMYNZ | 1 | Strong Buy | $14.00 | +677.78% | Initiates Coverage On | 6 months ago |
Lineage Cell Therapeutics IncLCTX | 1 | Strong Buy | $3.00 | +141.94% | Maintains | 7 months ago |
Citius Oncology IncCTOR | 1 | Strong Buy | $3.00 | +76.47% | Initiates Coverage On | 9 months ago |
Ocugen IncOCGN | 1 | Strong Buy | $4.00 | +300.00% | Initiates Coverage On | 10 months ago |
Fibrobiologics IncFBLG | 1 | Strong Buy | $12.00 | +1,937.35% | Initiates Coverage On | a year ago |
Longeveron IncLGVN | 2 | Strong Buy | $6.00 | +624.64% | Maintains | a year ago |
Lexaria Bioscience CorpLEXX | 2 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Dmk Pharmaceuticals CorpDMKPQ | 1 | Strong Buy | $1.50 | N/A | Initiates Coverage On | 2 years ago |
Acrivon Therapeutics IncACRV | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Kiora Pharmaceuticals IncKPRX | 3 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Alzamend Neuro IncALZN | 1 | Strong Buy | $2,025.00 | N/A | Initiates Coverage On | 2 years ago |
Mediwound LtdMDWD | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Biorestorative Therapies IncBRTX | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Atlantic International CorpATLN | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 4 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Citius Pharmaceuticals IncCTXR | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.